Japan, Nov. 10 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'INHIBITION OF HSD17B13 IN THE TREATMENT OF LIVER DISEASE IN PATIENTS EXPRESSING PNPLA3-I148M.' Other related details are as follows:
Application Number: JP,2024-017035
Category (FI): A61K31/7088,A61K31/713,A61P43/00,111,A61P35/00,C12N15/113,130@Z,A61P1/16,A61K48/00
Stage: Grant (IP right document published.)
Filing Date: Feb. 7, 2024
Publication Date: April 2, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
